药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Dacarbazine
Ocrelizumab
The risk or severity of adverse effects can be increased when Dasatinib is combined with Ocrelizumab.
Dacarbazine
Guselkumab
The risk or severity of adverse effects can be increased when Dasatinib is combined with Guselkumab.
Dacarbazine
Sirukumab
The risk or severity of adverse effects can be increased when Dasatinib is combined with Sirukumab.
Dacarbazine
Brodalumab
The risk or severity of adverse effects can be increased when Dasatinib is combined with Brodalumab.
Dacarbazine
Peficitinib
The risk or severity of adverse effects can be increased when Dasatinib is combined with Peficitinib.
Dacarbazine
Voclosporin
The risk or severity of adverse effects can be increased when Dasatinib is combined with Voclosporin.
Dacarbazine
Pirarubicin
The risk or severity of adverse effects can be increased when Dasatinib is combined with Pirarubicin.
Dacarbazine
Ravulizumab
The risk or severity of adverse effects can be increased when Dasatinib is combined with Ravulizumab.
Dacarbazine
Ixekizumab
The risk or severity of adverse effects can be increased when Dasatinib is combined with Ixekizumab.
Dacarbazine
Tepoxalin
The risk or severity of adverse effects can be increased when Dasatinib is combined with Tepoxalin.
Dacarbazine
Antilymphocyte immunoglobulin (horse)
The risk or severity of adverse effects can be increased when Dasatinib is combined with Antilymphocyte immunoglobulin (horse).
Dacarbazine
Peginterferon beta-1a
The risk or severity of adverse effects can be increased when Dasatinib is combined with Peginterferon beta-1a.
Dacarbazine
Tixocortol
The risk or severity of adverse effects can be increased when Dasatinib is combined with Tixocortol.
Dacarbazine
Dinutuximab
The risk or severity of adverse effects can be increased when Dasatinib is combined with Dinutuximab.
Dacarbazine
Blinatumomab
The risk or severity of adverse effects can be increased when Dasatinib is combined with Blinatumomab.
Dacarbazine
Vedolizumab
The risk or severity of adverse effects can be increased when Dasatinib is combined with Vedolizumab.
Dacarbazine
Obinutuzumab
The risk or severity of adverse effects can be increased when Dasatinib is combined with Obinutuzumab.
Dacarbazine
Dimethyl fumarate
The risk or severity of adverse effects can be increased when Dasatinib is combined with Dimethyl fumarate.
Dacarbazine
Belimumab
The risk or severity of adverse effects can be increased when Dasatinib is combined with Belimumab.
Dacarbazine
Eribulin
The risk or severity of adverse effects can be increased when Dasatinib is combined with Eribulin.